Tumor microenvironment
31 – 40 of 1969
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
Tuysuz, Emre Can LU ; Mourati, Eleni LU ; Rosberg, Rebecca LU
; Moskal, Aleksandra
LU
; Gialeli, Chrysostomi
LU
; Johansson, Elinn
LU
; Governa, Valeria
LU
; Belting, Mattias
LU
; Pietras, Alexander
LU
and Blom, Anna M
LU
(2024)
In Journal of Experimental and Clinical Cancer Research
43.
p.1-16
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
Godina, Christopher LU
; Belting, Mattias
LU
; Vallon-Christersson, Johan
LU
; Isaksson, Karolin
LU
; Bosch, Ana
LU
and Jernström, Helena
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
-
Mark
Targeting the stressed tumor niche of glioblastoma: Tumor microenvironment and surface antigens
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival
Lång, Kristina LU ; Sturesdotter, Li LU
; Bengtsson, Ylva
LU
; Larsson, Anna Maria
LU
and Sartor, Hanna
LU
(2024)
In Breast
75.
- Contribution to journal › Article
-
Mark
Assessment of somatosensory profiles by quantitative sensory testing in children and adolescents with and without cerebral palsy and chronic pain
- Contribution to journal › Article
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
Norbeck, Anna LU ; Bengtsson, Jesper ; Malander, Susanne LU
; Asp, Mihaela
LU
and Kannisto, Päivi
LU
(2024)
In Acta Oncologica
63.
p.728-735
- Contribution to journal › Article
-
Mark
Treatment with BRAF/MEK : inhibitors in mutant BRAF V600E papillary craniopharyngioma
Erfurth, Eva Marie LU ; Siesjö, Peter LU
; Sundgren, Pia C
LU
; Hammar, Björn
LU
and Kinhult, Sara
LU
(2024)
In Endocrine oncology (Bristol, England)
4(1).
- Contribution to journal › Article
-
Mark
Beyond HRD Status : Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer
Kjeldsen, Maj K. ; Jørgensen, Morten ; Grønseth, Dina Sofie B. ; Schønemann-Lund, Martin ; Nyvang, Gitte Bettina ; Haslund, Charlotte Aaquist ; Knudsen, Anja Oer ; Motavaf, Anne Krejbjerg ; Malander, Susanne LU
and Anttila, Maarit
, et al.
(2024)
In Cancer Research Communications
4(12).
p.3190-3200
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
Nilsson, Linn LU ; Khazaei, Somayeh LU ; Tryggvadottir, Helga LU ; Björner, Sofie LU ; Bressan, Alessandra ; Jirström, Karin LU
; Adrian, Gabriel
LU
; Falck, Anna-Karin
LU
; Borgquist, Signe
LU
and Isaksson, Karolin
LU
, et al.
(2024)
In Clinical Breast Cancer
24(3).
p.152-166
- Contribution to journal › Article
- 2023
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
Jujic, Amra LU
; Godina, Christopher
LU
; Belting, Mattias
LU
; Melander, Olle
LU
; Juul Holst, Jens
; Ahlqvist, Emma
LU
; Gomez, Maria F
LU
; Nilsson, Peter M
LU
; Jernström, Helena
LU
and Magnusson, Martin
LU
(2023)
In Scientific Reports
13.
p.1-11
- Contribution to journal › Article